- Home
- EUDA vs ADCT Comparison
EUDA vs ADCT Comparison
Compare EUDA & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- ADCT
- Stock Information
- Founded
- EUDA 2021
- ADCT 2011
- Country
- EUDA Singapore
- ADCT Switzerland
- Employees
- EUDA N/A
- ADCT N/A
- Industry
- EUDA Blank Checks
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- EUDA Finance
- ADCT Health Care
- Exchange
- EUDA Nasdaq
- ADCT Nasdaq
- Market Cap
- EUDA 139.3M
- ADCT 143.1M
- IPO Year
- EUDA N/A
- ADCT 2020
- Fundamental
- Price
- EUDA $3.68
- ADCT $1.41
- Analyst Decision
- EUDA
- ADCT Strong Buy
- Analyst Count
- EUDA 0
- ADCT 5
- Target Price
- EUDA N/A
- ADCT $7.75
- AVG Volume (30 Days)
- EUDA 105.3K
- ADCT 345.0K
- Earning Date
- EUDA 01-01-0001
- ADCT 03-27-2025
- Dividend Yield
- EUDA N/A
- ADCT N/A
- EPS Growth
- EUDA N/A
- ADCT N/A
- EPS
- EUDA N/A
- ADCT N/A
- Revenue
- EUDA $3,811,496.00
- ADCT $70,837,000.00
- Revenue This Year
- EUDA $66.63
- ADCT $11.56
- Revenue Next Year
- EUDA $119.95
- ADCT $17.03
- P/E Ratio
- EUDA N/A
- ADCT N/A
- Revenue Growth
- EUDA N/A
- ADCT 1.84
- 52 Week Low
- EUDA $1.64
- ADCT $1.28
- 52 Week High
- EUDA $6.30
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- EUDA 43.29
- ADCT 36.11
- Support Level
- EUDA $3.64
- ADCT $1.41
- Resistance Level
- EUDA $4.04
- ADCT $1.68
- Average True Range (ATR)
- EUDA 0.22
- ADCT 0.12
- MACD
- EUDA -0.01
- ADCT -0.04
- Stochastic Oscillator
- EUDA 14.06
- ADCT 20.32
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.